YPL108W Antibody

What is YPL108W and why is it studied?

YPL108W is an uncharacterized protein in Saccharomyces cerevisiae (Baker's yeast), particularly in strain ATCC 204508/S288c. This protein has been assigned the UniProt accession number Q02872. Despite its uncharacterized status, studying this protein is crucial for completing our understanding of the yeast proteome and potentially uncovering novel cellular functions and pathways. Antibodies against YPL108W enable researchers to investigate its expression patterns, subcellular localization, and potential interactions, which could provide insights into its biological role. The systematic study of uncharacterized yeast proteins like YPL108W contributes to our fundamental understanding of eukaryotic cell biology and may uncover conserved mechanisms relevant to human biology .

What types of YPL108W antibodies are available for research?

Based on available research materials, polyclonal antibodies against YPL108W are commercially available. Specifically, rabbit polyclonal antibodies that react with Saccharomyces cerevisiae strain 204508/S288c have been developed. These antibodies are typically purified using antigen-affinity methods and are of IgG isotype. Commercial sources like MyBioSource and CUSABIO offer these antibodies in different sizes (e.g., 2ml/0.1ml) for research applications . These polyclonal preparations recognize multiple epitopes on the YPL108W protein, potentially offering robust detection across different experimental conditions.

What are the common applications for YPL108W antibodies?

YPL108W antibodies are primarily used in:

• Western Blot (WB) analysis for protein detection and semi-quantification

• Enzyme-Linked Immunosorbent Assay (ELISA) for quantitative measurements

• Immunoprecipitation studies (though specific validation is required)

• Potentially in immunofluorescence for localization studies (requiring validation)

These applications enable researchers to detect, quantify, and localize YPL108W protein in yeast samples under various experimental conditions, contributing to functional characterization efforts . Each application requires specific optimization and validation to ensure reliable results, especially when working with an uncharacterized protein.

How should I store and handle YPL108W antibodies to maintain efficacy?

To maintain antibody efficacy:

• Storage conditions: Store antibodies at -20°C for long-term storage and at 4°C for short-term use (1-2 weeks). Avoid repeated freeze-thaw cycles by preparing small working aliquots.

• Handling precautions: Always handle antibodies with clean gloves to prevent contamination. Centrifuge briefly before opening vials to collect all liquid at the bottom.

• Buffer considerations: Most antibodies are supplied in buffers containing preservatives like sodium azide or glycerol. Be aware that sodium azide can inhibit some enzymatic reactions and is toxic.

• Stability assessments: Monitor antibody performance over time by including positive controls in each experiment. Declining signal intensity may indicate antibody degradation.

• Documentation: Maintain detailed records of antibody source, lot number, aliquot preparation dates, and experimental performance to track stability and reproducibility over time .

How can I validate the specificity of a YPL108W antibody for my particular experiments?

Validating antibody specificity is critical for ensuring reliable results, especially for less-characterized proteins like YPL108W. A comprehensive validation approach includes:

• Genetic controls: Test the antibody in YPL108W knockout/knockdown yeast strains, where the signal should be absent or significantly reduced.

• Overexpression controls: Test in strains overexpressing YPL108W, where signal should increase proportionally.

• Peptide competition assay: Pre-incubate the antibody with purified YPL108W protein or the immunizing peptide before application to samples. This should eliminate specific binding.

• Cross-reactivity assessment: Test the antibody against closely related yeast proteins to assess potential cross-reactivity.

• Multiple detection methods: Confirm results using at least two independent detection methods (e.g., Western blot and immunofluorescence).

• Mass spectrometry validation: Following immunoprecipitation with the YPL108W antibody, mass spectrometry can confirm the presence of YPL108W and identify any cross-reacting proteins .

The antibody characterization crisis has highlighted that approximately 50% of commercial antibodies fail to meet basic characterization standards, underscoring the importance of rigorous validation before experimental use .

What advanced experimental designs can help characterize the function of YPL108W using its antibody?

To characterize YPL108W function using antibody-based approaches:

• Temporal expression profiling: Monitor YPL108W expression across different growth phases, stress conditions, and metabolic states using quantitative Western blotting with the antibody.

• Subcellular fractionation: Combine cell fractionation with Western blotting to determine subcellular localization, which can provide functional clues.

• Immunoprecipitation-mass spectrometry (IP-MS): Use the YPL108W antibody to pull down protein complexes and identify interaction partners through mass spectrometry.

• Chromatin immunoprecipitation (ChIP): If YPL108W has potential DNA-binding properties, ChIP using the antibody can identify genomic binding sites.

• In situ proximity labeling: Combine antibody-mediated detection with proximity labeling techniques to identify proteins in close spatial proximity to YPL108W in vivo.

• Correlative microscopy: Integrate immunofluorescence with electron microscopy to precisely localize YPL108W at ultrastructural levels.

Each approach provides complementary information that, when integrated, can reveal functional contexts and potential regulatory roles of this uncharacterized protein .

How can differential expression of YPL108W be accurately quantified across experimental conditions?

For accurate quantification of YPL108W expression across conditions:

• Standardized sample preparation:

  • Harvest cells at precisely matched growth phases

  • Extract proteins using identical protocols to minimize technical variation

  • Determine total protein concentration using methods resistant to buffer interference

• Quantitative Western blotting protocol:

  • Use a dilution series of control samples to establish linearity of detection

  • Load equal amounts of total protein, verified by total protein staining

  • Include internal reference proteins from different cellular compartments

• Detection optimization:

  • Select detection systems with broad dynamic range (e.g., fluorescent secondary antibodies)

  • Capture images within the linear range of detection

  • Use digital image analysis with appropriate background correction

• Statistical rigor:

  • Perform a minimum of three biological replicates

  • Calculate coefficients of variation between replicates

  • Apply appropriate statistical tests with corrections for multiple comparisons

• Validation methods:

  • Confirm protein-level changes with mRNA quantification where possible

  • Verify with orthogonal methods such as mass spectrometry

  • Consider absolute quantification using purified recombinant YPL108W standards

What are optimal sample preparation methods for YPL108W detection in Western blots?

For effective detection of YPL108W in Western blots:

This protocol ensures efficient extraction and detection of YPL108W while minimizing common issues like high background or non-specific binding .

What controls should be included when using YPL108W antibodies in immunofluorescence studies?

For rigorous immunofluorescence studies with YPL108W antibodies:

• Negative controls:

  • Primary antibody omission (secondary antibody only)

  • Isotype control (non-specific rabbit IgG)

  • YPL108W deletion strain (if available)

  • Pre-immune serum control

• Positive controls:

  • YPL108W-overexpressing strain

  • Known subcellular marker co-staining (once localization is established)

• Specificity controls:

  • Peptide competition assay (pre-incubation with immunizing peptide)

  • Multiple antibodies targeting different epitopes of YPL108W (if available)

• Technical controls:

  • Autofluorescence control (no antibody sample)

  • Fixed but not permeabilized cells to control for membrane permeability

  • Single-color controls for spectral overlap correction in multi-color imaging

• Quantification controls:

  • Consistent exposure settings between samples

  • Z-stack imaging to ensure complete cellular volume assessment

  • Blinded analysis of images to prevent bias

Antibody characterization is critical for reproducibility in biomedical research. For yeast proteins like YPL108W, special attention must be paid to cell wall digestion and permeabilization steps to ensure antibody accessibility to intracellular targets.

How can I optimize immunoprecipitation protocols for YPL108W protein complex isolation?

For effective immunoprecipitation of YPL108W and associated proteins:

• Cell lysis optimization:

  • Use gentle lysis buffers to preserve protein-protein interactions (e.g., 150 mM NaCl, 50 mM Tris pH 7.5, 1% NP-40, 1 mM EDTA)

  • Include protease inhibitors and phosphatase inhibitors

  • Consider crosslinking with formaldehyde (0.1-1%) to stabilize transient interactions

• Pre-clearing step:

  • Incubate lysate with Protein A/G beads for 1 hour at 4°C to remove non-specific binding proteins

  • Remove beads by centrifugation before adding YPL108W antibody

• Antibody binding:

  • Use 2-5 μg of YPL108W antibody per 500 μg of total protein

  • Incubate overnight at 4°C with gentle rotation

  • Consider direct antibody conjugation to beads to avoid co-elution of antibody heavy/light chains

• Washing optimization:

  • Perform 4-5 washes with decreasing salt concentrations

  • Include a final wash with low-salt buffer to remove detergent

  • Monitor wash fractions for loss of specific signal

• Elution strategies:

  • Gentle elution with antibody-specific peptide if available

  • Standard elution with low pH glycine buffer (pH 2.5-3.0)

  • Direct elution in Laemmli buffer for Western blot analysis

• Verification methods:

  • Western blot a portion of the immunoprecipitate to confirm YPL108W pull-down

  • Silver stain to visualize co-immunoprecipitated proteins

  • Mass spectrometry for comprehensive interactome analysis

What are common issues when using YPL108W antibodies in Western blots and how can they be resolved?

It's estimated that approximately 50% of commercial antibodies fail to meet basic standards for characterization, which can lead to reliability issues in experimental results . For uncharacterized proteins like YPL108W, systematic troubleshooting is particularly important.

How can I determine if unexpected results with YPL108W antibodies are due to technical issues or biological significance?

When faced with unexpected results:

• Verify antibody performance:

  • Repeat experiments with new antibody aliquots

  • Test antibody in a system with known YPL108W expression patterns

  • Consider using a different antibody targeting YPL108W (if available)

• Validate at multiple levels:

  • Confirm protein-level findings with mRNA analysis (RT-qPCR)

  • Use tagged YPL108W constructs as an independent approach

  • Apply orthogonal detection methods (mass spectrometry)

• Systematic controls:

  • Include positive and negative controls in each experiment

  • Conduct dose-response or time-course studies to establish patterns

  • Test in multiple strains or under various conditions

• Distinguish biological from technical variation:

  • Calculate coefficient of variation between technical replicates

  • Perform sufficient biological replicates (minimum n=3)

  • Use appropriate statistical tests for significance

• Literature contextualization:

  • Compare results with published data on related proteins

  • Consider evolutionary conservation patterns

  • Consult databases for predicted functions or interactions

Research suggests that problems with antibody quality and characterization may contribute to financial losses of $0.4–1.8 billion per year in the United States alone, highlighting the importance of rigorous validation practices .

What advanced analytical approaches can resolve contradictory data when using YPL108W antibodies?

When facing contradictory data:

• Multi-epitope targeting strategy:

  • Use multiple antibodies targeting different regions of YPL108W

  • Compare results to identify region-specific detection patterns

  • Investigate potential post-translational modifications or processing events

• Correlative techniques:

  • Combine fluorescence microscopy with electron microscopy for high-resolution localization

  • Integrate biochemical fractionation with immunodetection for comprehensive distribution analysis

  • Cross-validate with proximity labeling techniques (BioID, APEX)

• Systems-level analysis:

  • Examine YPL108W expression/localization across comprehensive condition sets

  • Apply principal component analysis to identify major sources of variation

  • Use hierarchical clustering to identify patterns in seemingly contradictory data

• Genetic manipulation validation:

  • Create epitope-tagged versions of YPL108W at endogenous locus

  • Compare antibody-based detection with tag-based detection

  • Use CRISPR/Cas9 to introduce specific mutations in suspected functional domains

• Computational modeling:

  • Use structural prediction to identify potential conformational epitopes

  • Model potential protein interactions based on structural features

  • Simulate cellular contexts to explain condition-dependent results